Geburtshilfe

From Molecular Mechanisms to Novel Therapeutic Approaches

Pregnancy requires profound metabolic and cardiovascular adaptations by the maternal organism. Disruption of these adaptive processes can lead to serious pregnancy complications such as preeclampsia, which adversely affect both maternal health and fetal development.

Our research group investigates how the placenta, the vascular system, and maternal metabolism interact and how these interactions contribute to pregnancy disorders. Our goal is to identify disease-relevant signaling pathways and translate this knowledge into novel diagnostic and therapeutic strategies.

A current focus of our work is preeclampsia, one of the leading causes of maternal and perinatal morbidity worldwide. By combining clinical cohorts, advanced molecular analyses, and human-based experimental models, we aim to better understand the biological mechanisms underlying this disease and to develop new therapeutic approaches.

Contact

Hanna Allerkamp 
T: +43 316 385 13532

Ziele

Our Research Areas

  • Metabolic–Vascular Signaling Pathways in Pregnancy Disorders: We investigate how metabolic changes influence the interactions between the placenta, the vascular system, and maternal metabolism. To address these questions, we combine laboratory-based approaches with computational models of the uterine and fetoplacental vasculature.
  • Biomarkers and Clinical Cohorts: Through the analysis of blood samples and clinical data from pregnant individuals, we identify metabolic signatures and biomarker networks that may contribute to the prediction and characterization of pregnancy disorders.
  • Human-Based Testing Platforms for Novel Therapies: A central goal of our research is the development of a translational testing platform for pregnancy therapeutics. By integrating clinical data with human tissue models and innovative preclinical systems, we evaluate the efficacy and safety of novel therapies under physiologically relevant conditions.
  • Long-Term Vision: Our long-term objective is to establish an integrated platform for the development and evaluation of novel therapies in pregnancy. By combining cohort-derived data, molecular characterization, and human-relevant model systems, we aim to accelerate the translation of biological discoveries into clinically applicable treatments and ultimately improve maternal and child health.
Forschungsprojekte

Our project

  • GLP-1 Receptor Agonists in Preeclampsia Therapy (GRIP)
    The project GRIP investigates the potential of GLP-1 receptor agonists as a novel therapeutic strategy for preeclampsia. Using a human-relevant testing platform, we characterize the underlying metabolic–vascular mechanisms and evaluate the safety and efficacy of this drug class for future use in pregnancy.
    Funding: BioTechMed-Graz Young Researcher Group Program